News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Corcoran Gavin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Corcoran Gavin (Chief R&D Officer) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 16,002 shares
@ $0
Paid exercise price by delivering 6,211 shares
@ $3.46, valued at
$21.5k
Disposed/sold 16,002 restricted stock units
@ $0 |
|
| 04/17/2020 |
4
| Corcoran Gavin (EVP of R&D) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 63,700 options to buy
@ $3.45, valued at
$219.8k
Granted 42,400 restricted stock units
@ $0 |
|
| 09/24/2019 |
4
| Corcoran Gavin (EVP of R&D) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 32,003 restricted stock units
@ $0 |
|
| 04/17/2019 |
4
| Corcoran Gavin (EVP of R&D) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Granted 767,000 options to buy
@ $1.06, valued at
$813k
Granted 200,000 options to buy
@ $1.06, valued at
$212k
|
|
| 07/20/2018 |
4
| Corcoran Gavin (EVP of R&D) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Granted 250,000 options to buy
@ $2.46, valued at
$615k
Granted 200,000 options to buy
@ $2.46, valued at
$492k
|
|
|
|